Effects of three frequencies of self-monitored blood glucose on HbA1c and quality of life in patients with type 2 diabetes with once daily insulin and stable control: a randomized trial

Johanna Hortensius, Nanne Kleefstra, Gijs W D Landman, Bas T Houweling, Klaas H Groenier, Jaap J van der Bijl, Henk Bilo, Johanna Hortensius, Nanne Kleefstra, Gijs W D Landman, Bas T Houweling, Klaas H Groenier, Jaap J van der Bijl, Henk Bilo

Abstract

Objective: The optimal frequency of self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes (T2DM) with stable glycemic control is unknown. This study investigated effects of 3 frequencies of SMBG on glycemic control and quality of life after 9 months in patients using one long-acting insulin injection a day. In an open-label, multi-center, primary-care, parallel (1:1:1) randomized trial in the Netherlands including patients with T2DM, HbA1c ≤ 58 mmol/mol (≤ 7.5%), stable glycemic control, treated with one insulin injection daily, three frequencies of 4-point glucose measurements (before meals and bedtime) were weekly (n = 22), every 2 weeks (n = 16) and monthly (n = 20) were compared.

Results: A total of 58 patients with T2DM were included by 38 general practitioners, which was lower then anticipated. There were no significant between group differences in HbA1c (mmol/mol); group C compared to A and B; - 2.7 (95% CI - 6.4, 1.0) and - 1.0 (95% CI - 4.9, 3.0) and quality of life. Baring in mind the lower than anticipated inclusion rate, there were no significant differences in HbA1c and quality of life between three different frequencies of SMBG in patients with stable glycemic control using one long-acting insulin injection. Trial registration NCT01460459, registered 10-2011, recruitment between 05-2011 and 12-2011.

Keywords: Frequency; Insulin-treated; Self-monitoring of blood glucose; Type 2 diabetes.

Figures

Fig. 1
Fig. 1
Flow diagram. Number of participants in stages of the trial

References

    1. Nathan DM, McKitrick C, Larkin M, Schaffran R, Singer DE. Glycemic control in diabetes mellitus: have changes in therapy made a difference? Am J Med. 1996;100:157–163. doi: 10.1016/S0002-9343(97)89453-3.
    1. Karter AJ, Ackerson LM, Darbinian JA, D’Agostino RB, Jr, Ferrara A, Liu J, Selby JV. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med. 2001;111:1–9. doi: 10.1016/S0002-9343(01)00742-2.
    1. Hortensius J, Kars MC, Wierenga WS, Kleefstra N, Bilo HJ, van der Bijl JJ. Perspectives of patients with type 1 or insulin-treated type 2 diabetes on self-monitoring of blood glucose: a qualitative study. BMC Public Health. 2012;12:167. doi: 10.1186/1471-2458-12-167.
    1. Vincze G, Barner JC, Lopez D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diab Educ. 2004;30:112–125. doi: 10.1177/014572170403000119.
    1. Wa F. Barriers and behaviours in blood glucose monitoring. US Endocr Dis. 2007;2:51–53.
    1. Hortensius J, Kleefstra N, Houweling ST, van der Bijl JJ, Gans RO, Bilo HJ. What do professionals recommend regarding the frequency of self-monitoring of blood glucose? Neth J Med. 2012;70:287–291.
    1. Federation DD. Multidisciplinary guideline self-monitoring of blood glucose by people with diabetes. 2012. . Accessed 1 Dec 2013.
    1. Berard LD, Blumer I, Houlden R, Miller D, Woo V. Monitoring glycemic control. Can J Diab. 2013;37(Supplement 1):S35–S39. doi: 10.1016/j.jcjd.2013.01.017.
    1. A. American Diabetes Standards of medical care in diabetes—2013. Diabetes Care. 2013;36(Suppl 1):S11–S66. doi: 10.2337/dc13-S011.
    1. Kleefstra N, Hortensius J, Logtenberg SJ, Slingerland RJ, Groenier KH, Houweling ST, Gans RO, van Ballegooie E, Bilo HJ. Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC) Neth J Med. 2010;68:311–316.
    1. Kleefstra N, Hortensius J, van Hateren KJ, Logtenberg SJ, Houweling ST, Gans RO, Bilo HJ. Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview. Diab Metabol Syndr Obes Targets Ther. 2009;2:155–163. doi: 10.2147/DMSO.S4580.
    1. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51:1171–1178. doi: 10.1016/S0895-4356(98)00109-7.
    1. Keller SD, Majkut TC, Kosinski M, Ware JE., Jr Monitoring health outcomes among patients with arthritis using the SF-36 Health Survey: overview. Med Care. 1999;37:MS1–MS9. doi: 10.1097/00005650-199901000-00001.
    1. Snoek FJ, Pouwer F, Welch GW, Polonsky WH. Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the problem areas in diabetes scale. Diabetes Care. 2000;23:1305–1309. doi: 10.2337/diacare.23.9.1305.
    1. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23:943–950. doi: 10.2337/diacare.23.7.943.
    1. Ubink-Veltmaat LJ, Bilo HJ, Groenier KH, Houweling ST, Rischen RO, Meyboom-de Jong B. Prevalence, incidence and mortality of type 2 diabetes mellitus revisited: a prospective population-based study in The Netherlands (ZODIAC-1) Eur J Epidemiol. 2003;18:793–800. doi: 10.1023/A:1025369623365.
    1. World Health Organization . Adherence to long-term therapies. Evidence for action. Geneva: WHO; 2003.
    1. Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, Bokhari SU, Duckworth WC, S. Diabetes Outcomes in Veterans Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the Diabetes Outcomes in Veterans Study (DOVES) Diabetes Care. 2003;26:1759–1763. doi: 10.2337/diacare.26.6.1759.
    1. Schutt M, Kern W, Krause U, Busch P, Dapp A, Grziwotz R, Mayer I, Rosenbauer J, Wagner C, Zimmermann A, Kerner W, Holl RW, DPV Initiative Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diab. 2006;114:384–388. doi: 10.1055/s-2006-924152.
    1. Secnik K, Yurgin N, Lage MJ, McDonald-Everett C. Patterns of blood glucose monitoring in relation to glycemic control among patients with type 2 diabetes in the UK. J Diabetes Complications. 2007;21:181–186. doi: 10.1016/j.jdiacomp.2006.04.003.
    1. Evans JM, Newton RW, Ruta DA, MacDonald TM, Stevenson RJ, Morris AD. Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database. BMJ. 1999;319:83–86. doi: 10.1136/bmj.319.7202.83.
    1. Harris MI, National H, S. Nutrition Examination Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes. Diabetes Care. 2001;24:979–982. doi: 10.2337/diacare.24.6.979.
    1. G. International Hypoglycaemia Study Glucose concentrations of less than 3.0 mmol/L (54 mg/dL) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2017;40:155–157. doi: 10.2337/dc16-2215.
    1. Hortensius J, van der Bijl JJ, Kleefstra N, Houweling ST, Bilo HJ. Self-monitoring of blood glucose: professional advice and daily practice of patients with diabetes. Diab Educ. 2012;38:101–107. doi: 10.1177/0145721711427787.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する